– Report will be subject of public meeting of California Technology Assessment Forum (CTAF) on March 10, 2014 –

San Francisco, Calif., February 12, 2014 – The Institute for Clinical and Economic Review (ICER) has posted the draft report “The Comparative Clinical Effectiveness and Value of Simeprevir and Sofosbuvir in the Treatment of Chronic Hepatitis C Infection” for public comment. This report will be the subject of deliberation and vote at the next public meeting of the California Technology Assessment Forum (CTAF) on Monday, March 10 in San Francisco, California. This report aims to help the members of CTAF and the public understand the latest evidence on the relative effectiveness and value of different treatment options for individuals diagnosed with chronic hepatitis C. The report will be available for public comments until Monday, March 3, 2014.

Meeting Details
Date: Monday, March 10, 2014
Time: 10:00 AM – 4:00 PM PT
Location: Mission Bay Conference Center at UCSF
1675 Owens Street
San Francisco, CA 94143

Members of the public wishing to attend the meeting should register by Friday, March 7, 2014 by clicking here. The CTAF website also includes instructions for those wishing to submit written comments prior to the meeting, and for those requesting the opportunity to make public comments at the meeting. Members of the public wishing to deliver an oral comment during the public meeting must email ctaf@icer-review.org by 5:00 PM PT Friday, March 7, 2014. Availability of time slots for public comments is limited.

An audio recording of the March 10, 2014 meeting will be made available on the CTAF website following the meeting for members of the public unable to attend the in-person meeting.

About CTAF
The California Technology Assessment Forum, a flagship initiative of the Institute for Clinical and Economic Review (ICER), is dedicated to providing credible, evidence-based information about new and emerging medical technologies and delivery system interventions. ICER recently assumed leadership of CTAF from the Blue Shield of California Foundation, which continues to provide lead funding for the program. For more information about CTAF, please visit www.ctaf.org.

About ICER
The Institute for Clinical and Economic Review (ICER) is an independent non-profit health care research organization dedicated to improving the interpretation and application of evidence in the health care system.